You are here
Articles on Gastrointestinal Cancer
A selection of peer-reviewed articles on Gastrointestinal Cancer. All content available on the Advances in Gastrointestinal Cancer Resource Center, including original and review articles, interviews, guidelines and congress highlights, is independently selected by the members of the Editorial Board.
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
Al-Batran SE, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka SAnn Oncol 2016 Jan 7. pii: mdv625. [Epub ahead of print]
Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data
Janowitz T, Thuss-Patience P, Marshall A, Kang JH, Connell C, Cook N, et al.Br J Cancer 2016 Feb 16;114(4):381-7
Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, etal.Ann Oncol. 2016 Mar;27(3):494-501
Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival: Systematic Review and Pooled Analysis
Markar SR, Mikhail S, Malietzis G, Athanasiou T, Mariette C, Sasako M, Hanna GBAnn Surg. 2016 Jan 16. [Epub ahead of print]
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, et al.Lancet Oncol. 2016 Mar;17(3):309-18
Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
Sook Ryun Park, Young Soo Park, Min-Hee Ryu, Baek-Yeol Ryoo, Chang Gok Woo, Hwoon-Yong Jung, Jeong Hoon Lee, Gin Hyug Lee, Yoon-Koo Kang
European Journal of Cancer, January 2016, Pages 42 - 50
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Li J, Qin S, Xu J, Xiong J, Wu C, Bai Y, et al.J Clin Oncol. 2016 Feb 16. [Epub ahead of print]
Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone
Robb WB, Messager M, Dahan L, Mornex F, Maillard E, D'Journo XB, et al.Br J Surg. 2016 Jan;103(1):117-25.
Impact of number of [(18) F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer
Miyata H, Yamasaki M, Makino T, Tatsumi M, Miyazaki Y, Takahashi T, et al.Br J Surg. 2016 Jan;103(1):97-104.